Results 161 to 170 of about 42,124 (246)

STAMBP Accelerates Progression and Tamoxifen Resistance of Breast Cancer Through Deubiquitinating ERα. [PDF]

Biomolecules
Wang Z, Gu L, Yang M, Zhou Y, Qin X, Xiong C.   +5 more
europepmc   +1 more source

RelB-activated GPX4 inhibits ferroptosis and confers tamoxifen resistance in breast cancer. [PDF]

Redox Biol, 2023
Xu Z, Wang X, Sun W, Xu F, Kou H, Hu W, Zhang Y, Jiang Q, Tang J, Xu Y.   +9 more
europepmc   +1 more source

The EGR1/caspase-14/HIF-1α axis mediates tamoxifen resistance in MCF-7 breast cancer cells. [PDF]

Open Life Sci
Ji F, Zhao A, Chen Q, Li C, Huang L.
europepmc   +1 more source

BMP1 Appears to be Involved in GPER1-mediated Progression and Tamoxifen Resistance of Luminal A Breast Cancer Cells. [PDF]

Cancer Genomics Proteomics
Wert K, Jentsch J, Gallwas J, Gründker C.   +3 more
europepmc   +1 more source

circRNA-SFMBT2 orchestrates ERα activation to drive tamoxifen resistance in breast cancer cells. [PDF]

Cell Death Dis, 2023
Li Z, Li Y, Han D, Wang X, Li C, Chen T, Li W, Liang Y, Luo D, Chen B, Wang L, Zhao W, Yang Q.   +12 more
europepmc   +1 more source

Genetic and epigenetic contribution to tamoxifen resistance in breast cancer, concepts to drive therapeutic strategies. [PDF]

Discov Oncol
Jahangiri R.
europepmc   +1 more source

Differential expression of mTOR signalling components in drug resistance in ovarian cancer

, 2010
This article has been made available through the Brunel Open Access Publishing Fund and is available from the specified link - Copyright @ 2010 The International Institute of Anticancer Research.Background/Aim: A limitation to successful cancer ...
Karteris, E, Foster, H, Goumenou, A, Pados, G, Harvey, AJ, Coley, HM   +5 more
core  

Hsa_circ_0062522 affects the progression and tamoxifen resistance of estrogen receptor-positive breast cancer by targeting miR-3163. [PDF]

Discov Oncol
Bian Y, Ma Y, Xu Y, Mao J, Huang L.
europepmc   +1 more source

Tamoxifen resistance-related ceRNA network for breast cancer. [PDF]

Front Cell Dev Biol, 2022
Qiao Z, Xing Y, Zhang Q, Tang Y, Feng R, Pang W.   +5 more
europepmc   +1 more source

Dual action of pyrimidine derivatives: Targeting tamoxifen resistance in breast cancer. [PDF]

Transl Oncol
Yuan J, Wang G, Beeraka NM, Zhang H, Wang Q, Zhang D, Wang M, Ravish A, Chinnathambi A, Alharbi SA, Rangappa KS, Nikolenko VN, Basappa B, Yang L.   +13 more
europepmc   +1 more source